This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. billion to develop data centers in Spain. In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificialintelligence.
Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund just two years after its first to hunt for startups that are using artificialintelligence to develop new medicines. Venture funding to AI-related biotech and healthcare startups hit only $4.8
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. and AI product development. Sierra , $175M, artificialintelligence: If you want to have your company’s valuation skyrocket in the blink of an eye, start an AI startup.
Lambda , $480M, artificialintelligence: Lambda, which offers cloud computing services and hardware for training artificialintelligence software, raised a $480 million Series D co-led by Andra Capital and SGW. Lambda is also a provider of the latest GPUs by Nvidia , which are highly sought after by AI developers.
Healthcare startups using artificialintelligence have come out of the gate hot in the new year when it comes to fundraising. Also last week, Palo Alto, California-based Hippocratic AI , which develops a safety-focused large language model for healthcare, safety and accuracy, raised a $141 million Series B valuing the company at $1.6
billion globally went to companies applying advances in artificialintelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. The smash hit of the past year was Tempus AI , an artificialintelligence precision medicine company that went public in June.
OpenAI , $6.6B, artificialintelligence: OpenAI announced its long-awaited raise of $6.6 tied) Poolside , $500M, artificialintelligence: Poolside closed a $500 million Series B led by Bain Capital Ventures. The startup builds artificialintelligence software for programmers. billion, per Crunchbase.
Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.
Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificialintelligence to biotech to energy. tied) Anthropic , $1B, artificialintelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google.
While some things tend to slow as the year winds down, artificialintelligence fundraising apparently isn’t one of them. xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. and AI product development.
Fleetio , $450M, fleet management: Fleet optimization software platform developer Fleetio locked up a $450 million round to finance the acquisition of maintenance authorization platform Auto Integrate. Island , $250M, cybersecurity: Dallas-based enterprise browser developer Island raised a $250 million Series E at a $4.8
xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. Anthropic , $4B, artificialintelligence: Amazon has agreed to invest another $4 billion in AI startup Anthropic — a ChatGPT rival with its AI assistant Claude.
billion to develop data centers in Spain. In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificialintelligence. Last year it was reported the worlds largest asset manager plans to invest $8.2
Artificialintelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificialintelligence in healthcare. Healthtech startup RedBrick AI has raised $4.6 But researchers need much of their initial time preparing data for training AI systems.
At Writer, we’re not just creating LLMs that can execute tasks but developing advanced AI systems that deliver mission-critical enterprise work,” said co-founder and CEO May Habib. Artificialintelligence equals real cash Writer’s new round is just the latest example of investors’ never-ending thirst for all things AI.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. The company plans to use the tech to develop gene therapies for monogenic liver diseases and cell therapies for autoimmune diseases.
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”
While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns. This includes a $405 million Series F for battery technology company Form Energy and a $400 million Series A for obesity drug developer Kailera Therapeutics. billion Series C in May.
In addition to biotech, Russek felt there also needed to be software and automation components. Finally, artificialintelligence-powered automation and engineering components are designed to remote-monitor the water quality, regulate temperature and oxygenation and feed the shrimp. So they created Atarraya, a U.S.-based
Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. Founded in 2017, the company has raised nearly $155 million, per Crunchbase.
However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificialintelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.
Department of Energy ’s Milestone-Based Fusion Development Program. Pika , $80M, artificialintelligence: It never takes us long to get to an AI startup on this list. tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. No lead investor was announced.
Aside from that, the week saw some big rounds from cybersecurity, travel and of course, biotech. The company will use some of the new proceeds for the development of Arsenal-1 — a more than 5 million-square-foot production space designed to produce tens of thousands of autonomous military systems annually.
Safe Superintelligence , $1B, artificialintelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital. Arsenal Biosciences , $325M, biotech: The big biotech raise of the week went to South San Francisco-based Arsenal Biosciences.
OpenAI , $6.6B, artificialintelligence: OpenAI announced its long-awaited raise of $6.6 Poolside , $500M, artificialintelligence: Most weeks a half-billion-dollar round would top this list — but this isn’t most weeks. The startup builds artificialintelligence software for programmers.
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. ” Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies. ’,” said Solomon.
Latigo Biotherapeutics , $150M, biotech: Many patients shy away from taking opioids while many doctors are reluctant to prescribe the painkillers. Thousand Oaks, California-based Latigo Biotherapeutics is developing a completely different option for pain relief and raised a $150 million Series B led by funds managed by Blue Owl for it.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
xAI , $6B, artificialintelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. CoreWeave , $1.1B, artificialintelligence: Another big AI-related funding round.
This week’s theme was definitely AI, as many of the largest rounds went to startups using AI in coding or biotech. Xaira Therapeutics , $1B, biotech: The biggest round this week was really big. Augment , $227M, artificialintelligence: AI coding startups made a big splash this week. billion in March 2023.
Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificialintelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificialintelligence software. billion valuation.
Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.
When I started at Novanta about five years ago, my first mission was to bring scalability to our Enterprise solutions, as well as developing a digital roadmap to modernize the technology footprint, reduce technical debt, and explore strategies to ensure that we’re growing at scale. Then I started working.
The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.
A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4
After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.
So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”
Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificialintelligence: This week was like many — one topped with a big AI round. The startup will use the new cash to grow its user base and add developer tools.
Its a good time to be an AI chip developer. Early last year, application security developer Snyk reported it grew its revenue by 50% to $220 million in 2023, while also cutting its losses by 33%, according to the companys Directors Report filed with the U.K.s Nevertheless, it seems almost certain to go public soon. Companies House.
The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp.
Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio. The biotech uses AI-powered protein design to program immune cells battling tumors. The company also uses artificialintelligence to help members get care faster. It is the company’s first disclosed round, per Crunchbase.
North American startup funding perked up in the second quarter, bolstered by early-stage investment around artificialintelligence. Artificialintelligence remains the runaway favorite investment theme, as AI-focused startups pulled in $16.8 Overall, investors put $45.3 and Canadian startups in the second quarter of 2024.
Eight startups raised $100 million or more this week as a biotech and financial services company led the way. The startup is focused on developing therapeutics for the treatment of cardiovascular diseases. Scorpion Therapeutics , $150M, biotech: Yet another big biotech round. Notice anything missing?
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content